Table 2.
Characteristics of 82 transplant recipients with positive plasma CMV PCR results during the study period
| Transplant type and characteristic | No. of patientsa |
|---|---|
| Total | 82 (100) |
| SOT | 27 (32.9) |
| CMV status at transplantation | |
| R+/D+ | 15 |
| R+/D− | 5 |
| R−/D+ | 6 |
| R+/D unknown | 1 |
| Prophylaxis | |
| Acyclovir | 3 |
| Valganciclovir | 15 |
| None | 9 |
| HSCT | 55 (67.1) |
| Allogeneic | 53 |
| Autologousb | 2 |
| CMV status at transplantation | |
| R+/D+ | 29 |
| R+/D− | 22 |
| R−/D+ | 4 |
| Prophylaxis | 53 |
| Acyclovir | 51 |
| Valganciclovir | 0 |
| None | 2 |
a
Numbers in parentheses are percentages of patients.
b
The two autologous HSCT transplants were CMV positive (R+) at transplantation.